Telemedicine and the Prescribing of Controlled Substances After the End of The Covid-19 Pandemic Emergency: DEA Announces Two Significant Proposed Rules: Read the Summary Below, But Learn All the Details and More at HPM’s Webinar on March 23, 2023 (Details Forthcoming….)
FDA Law Blog
FEBRUARY 27, 2023
The Act also established new definitions for “Internet,” “online pharmacy,” “practice of telemedicine,” among others. If an in-person evaluation is performed by either a referring provider or the prescribing provider, the patient may also receive schedule II controlled substances, consistent with Ryan Haight requirements already in place.
59 
Let's personalize your content